Cargando…

PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells

The regulatory transcriptional factor PATZ1 is constantly downregulated in human thyroid cancer where it acts as a tumour suppressor by targeting p53-dependent genes involved in Epithelial-Mesenchymal Transition and cell migration. The aim of the present work was to elucidate the upstream signalling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitiello, Michela, Valentino, Teresa, De Menna, Marta, Crescenzi, Elvira, Francesca, Paola, Rea, Domenica, Arra, Claudio, Fusco, Alfredo, De Vita, Gabriella, Cerchia, Laura, Fedele, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850481/ https://www.ncbi.nlm.nih.gov/pubmed/27125250 http://dx.doi.org/10.1038/srep25268

Ejemplares similares

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene
por: Vitiello, Michela, et al.
Publicado: (2019)

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
por: Monaco, Mario, et al.
Publicado: (2018)

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement
por: Fedele, Monica, et al.
Publicado: (2017)

The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation
por: Mancinelli, Sara, et al.
Publicado: (2021)

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype
por: Guadagno, Elia, et al.
Publicado: (2017)

PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration
por: Chiappetta, Gennaro, et al.
Publicado: (2015)

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas
por: Franco, Renato, et al.
Publicado: (2016)

PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context
por: Valentino, T, et al.
Publicado: (2013)

PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas
por: Passariello, Annalisa, et al.
Publicado: (2019)

PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype
por: Lucà, Stefano, et al.
Publicado: (2023)

The dosage of Patz1 modulates reprogramming process
por: Ma, Hui, et al.
Publicado: (2014)

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis
por: Cammarota, Francesca, et al.
Publicado: (2015)

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells
Publicado: (1998)

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells.
por: Liu, H. S., et al.
Publicado: (1998)

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
por: Camorani, Simona, et al.
Publicado: (2017)

Structural analysis of the PATZ1 BTB domain homodimer
por: Piepoli, Sofia, et al.
Publicado: (2020)

PATZ1 Induces Apoptosis through PUMA in Glioblastoma
por: Tao, Xiang, et al.
Publicado: (2022)

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB
por: Camorani, Simona, et al.
Publicado: (2018)

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.
por: Arends, M. J., et al.
Publicado: (1993)

Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin
por: Limtrakul, Porn-ngarm, et al.
Publicado: (2001)

Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene-bearing mice
por: Chen, Guan-Jie, et al.
Publicado: (1993)

Ha-ras Oncogene Effect on DNA Content and Chromatin Supraorganization in benzo[a]pyrene-Transformed Human Breast Epithelial Cells
por: Mello, Maria Luiza S., et al.
Publicado: (1999)

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
por: Camorani, Simona, et al.
Publicado: (2015)

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
por: Magaki, Mie, et al.
Publicado: (2016)

Transgenic Rats Carrying Human c‐Ha‐ras Proto‐oncogene Are Highly Susceptible to N‐Nitrosomethylbenzylamine Induction of Esophageal Tumorigenesis
por: Asamoto, Makoto, et al.
Publicado: (2002)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Oxidative Stress Posttranslationally Regulates the Expression of Ha-Ras and Ki-Ras in Cultured Astrocytes
por: Messina, Samantha, et al.
Publicado: (2012)

Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL 60 cells
Publicado: (1986)

Nuclear and Nucleolar Image Analysis of Human Breast Epithelial Cells Transformed by benzo[a]pyrene and Transfected with the c-Ha-ras oncogene
por: Barbisan, Luís Fernando, et al.
Publicado: (1998)

Mammary Carcinomas Induced in Human c‐Ha‐ras Proto‐oncogene Transgenic Rats Are Estrogen‐independent, but Responsive to d‐Limonene Treatment
por: Asamoto, Makoto, et al.
Publicado: (2002)

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
por: East, Philip, et al.
Publicado: (2022)

Ha-ras restriction fragment length polymorphisms in colorectal cancer.
por: Wyllie, F. S., et al.
Publicado: (1988)

Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.
por: Ceccherini-Nelli, L., et al.
Publicado: (1987)

Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.
por: Levy, P., et al.
Publicado: (1996)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts
Publicado: (1990)

Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts
por: Smaldone, Silvia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rkbvgpoknruepfs53k4a80kgrm